. . . . . . . "[Thus, the expression levels of PARP1 and DNA ligase III? serve as biomarkers to identify a subgroup of CML patients who may be candidates for therapies that target the ALT NHEJ pathway when treatment with TKIs has failed.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:10:17+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .